Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Feigin

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Pharmacology|June 7, 2018
GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic TargetsPaul A Insel, Krishna Sriram, Shu Z Wiley, et al.
Science Advances|September 2, 2022
Endogenous DOPA inhibits melanoma through suppression of CHRM1 signalingMiriam Doepner, Inyoung Lee, Christopher A Natale, et al.
Cancer Research Communications|April 17, 2026
Alprazolam reduces inflammatory cytokine production in pancreatic cancer-associated fibroblastsHunter D Reavis, Aditi H Chaubey, Amanda L Smythers, et al.
Nature Genetics|May 9, 2017
Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinomaMichael E Feigin, Tyler Garvin, Peter Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2023
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic CancerAbigail C Cornwell, Arwen A Tisdale, Swati Venkat, et al.
RNA (New York, N.Y.)|January 8, 2024
CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processingAbdulrahman A Alahmari, Aditi H Chaubey, Venkata S Jonnakuti, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancerKathryn E Maraszek, Arwen A Tisdale, Hunter D Reavis, et al.
Cell|January 6, 2015
Organoid models of human and mouse ductal pancreatic cancerSylvia F Boj, Chang-Il Hwang, Lindsey A Baker, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Pharmacology|June 7, 2018
GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic TargetsPaul A Insel, Krishna Sriram, Shu Z Wiley, et al.
Science Advances|September 2, 2022
Endogenous DOPA inhibits melanoma through suppression of CHRM1 signalingMiriam Doepner, Inyoung Lee, Christopher A Natale, et al.
Cancer Research Communications|April 17, 2026
Alprazolam reduces inflammatory cytokine production in pancreatic cancer-associated fibroblastsHunter D Reavis, Aditi H Chaubey, Amanda L Smythers, et al.
Nature Genetics|May 9, 2017
Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinomaMichael E Feigin, Tyler Garvin, Peter Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2023
Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic CancerAbigail C Cornwell, Arwen A Tisdale, Swati Venkat, et al.
RNA (New York, N.Y.)|January 8, 2024
CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processingAbdulrahman A Alahmari, Aditi H Chaubey, Venkata S Jonnakuti, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancerKathryn E Maraszek, Arwen A Tisdale, Hunter D Reavis, et al.
Cell|January 6, 2015
Organoid models of human and mouse ductal pancreatic cancerSylvia F Boj, Chang-Il Hwang, Lindsey A Baker, et al.
Pageof 3